Yoshida, Y., Yamazaki, K., Mizusawa, J., Satoh, M., Hinoi, T., Tsuchida, A., Otsuka, K., Sato, T., Watanabe, M., Baba, H., Kimura, H., Idani, H., Kanazawa, A., Fukunaga, M., Okuda, J., Tajima, Y., Hasegawa, H., Katayama, H., Hamaguchi, T., & Shimada, Y. (n.d.). 2129 Predictive factor for toxicities and treatment termination in adjuvant capecitabine therapy for stage III colorectal cancer; based on the data of a randomized trial, JCOG0910. European journal of cancer, 51, S375–. http://access.bl.uk/ark:/81055/vdc_100030628213.0x000064